ARTICLE | Company News
Entelos Inc., UCB deal
January 28, 2008 8:00 AM UTC
UCB's UCB Pharma S.A. subsidiary and Entelos will use Entelos' PhysioLab platform to conduct research with an in silico model of rheumatoid arthritis (RA). Further terms were not disclosed. ...